Ins and Outs

February 10th, 2009 News

  • MMR doctor Andrew Wakefield fixed data on autism… [The Sunday Times]
  • Genome sequencing: the third generation… [Nature]
  • B&W and Covidien to develop U.S. source of Molybdenum-99, a key medical isotope… [Babcock & Wilcox]
  • St. Jude Medical Announces U.S. Approval of Industry’s First Connector System Designed to Simplify Implant Process for Cardiac Resynchronization Therapy Devices… [St. Jude Medical]
  • Touch Bionics introduces the new i-LIMB Skin… [Touch Bionics]
  • Philips and Immunetrics join forces to research advanced solutions for infectious disease in critical care… [Philips]
  • Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents… [Boston Scientific]
  • Brainsway to run trial of Deep TMS transcranial magnetic stimulation device at Pittsburgh VA hospital… [Globes]
  • Test spots prions on equipment … [BBC]
  • Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study… [Clinical Pharmacology & Therapeutics]
  • Immune cell activation under the microscope… [RIKEN Institute]
  • Multiple genes implicated in autism… [MIT]
  • RNA interference can suppress ovarian tumor growth… [MIT]
  • Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative… [Nature Clinical Practice Rheumatology]
  • A possible treatment for Rett syndrome… [MIT]
  • What Makes Chuck Grassley Tick? [WSJ]
  • Venus Rising… [Chicago Mag]

    • Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

    © Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.

    MED TECH TRANSFORMS THE WORLD

    Exclusive Medgadget news in your mailbox!

    Your information will never be shared with any third party.

    X